Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSG | P08311 | 3/20 | 0.50 |
| ▸ | CMA1 | P23946 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2957410 | 1.00 | CTSG (0.50) | CTSGCMA1GAAMAPTMAPK1 | |
| SCHEMBL1023659 | 0.86 | GAA (0.47) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL21373234 | 0.86 | PPARG (0.49) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL21373232 | 0.86 | PPARG (0.49) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL10692667 | 0.85 | PPARG (0.55) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL7100965 | 0.85 | PPARG (0.55) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL10690468 | 0.83 | PPARG (0.51) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL10690483 | 0.83 | PPARG (0.51) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL28085748 | 0.82 | MAPK1 (0.49) | GAAMAPTMAPK1NPSR1MMP9 | |
| SCHEMBL10690475 | 0.82 | MMP9 (0.48) | GAAMAPTMAPK1NPSR1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1552269-A2 | FORMALDEHYDE-AMMONIUM SALT COMPLEXES FOR THE STABILIZATION OF BLOOD CELLS | Coulter International Corp. (US) | 2005-07-13 | — | — | EP | claimed |
| US-6913932-B2 | Formaldehyde-ammonium salt complexes for the stabilization of blood cells | BECKMAN COULTER, INC. (US) | 2005-07-05 | — | — | US | claimed |
| WO-2004017895-A2 | FORMALDEHYDE-AMMONIUM SALT COMPLEXES FOR THE STABILIZATION OF BLOOD CELLS | COULTER INTERNATIONAL CORP. (US) | 2004-03-04 | — | — | WO | claimed |
| US-20040038424-A1 | Formaldehyde-ammonium salt complexes for the stabilization of blood cells | BECKMAN COULTER, INC. | 2004-02-26 | — | — | US | claimed |
| EP-3529371-A1 | A FUNCTIONAL DETECTION ASSAY DEVOID OF ANTIBODIES FOR SEROTYPING OF BOTULINUM NEUROTOXINS | Toxogen GmbH (DE) | 2019-08-28 | — | — | EP | disclosed |
| WO-2018073370-A1 | A FUNCTIONAL DETECTION ASSAY DEVOID OF ANTIBODIES FOR SEROTYPING OF BOTULINUM NEUROTOXINS | TOXOGEN GMBH (DE) | 2018-04-26 | — | — | WO | disclosed |
| US-20140308668-A1 | Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes SImplex Virus | MEDICAL DIAGNOSTIC LABORATORIES L. L. C. | 2014-10-16 | — | — | US | disclosed |
| US-8778331-B2 | Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes simplex virus | MEDICAL DIAGNOSTIC LABORATORIES, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-8309788-B2 | Protease inhibitors in absorbent articles | THE PROCTER AND GAMBLE COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8262634-B1 | Absorbent article having barrier sheet against the migration of the skin care composition | THE PROCTER & GAMBLE COMPANY (US) | 2012-09-11 | — | — | US | disclosed |
| US-20090325146-A1 | Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes | MEDICAL DIAGNOSTIC LABORATORIES, LLC (US) | 2009-12-31 | — | — | US | disclosed |
| EP-1178846-B1 | ABSORBENT ARTICLE WITH SKIN CARE COMPOSITION | PROCTER & GAMBLE (US) | 2009-09-02 | — | — | EP | disclosed |
| WO-1997037044-A1 | NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF | ASTRA AKTIEBOLAG (SE) | 1997-10-09 | — | — | WO | disclosed |
| EP-0787016-A1 | SECRETORY LEUKOCYTE PROTEASE INHIBITOR AS AN INHIBITOR OF TRYPTASE | Bayer Corporation (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1997019098-A1 | NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI FOR DIAGNOSTICS AND THERAPEUTICS | ASTRA AKTIEBOLAG (SE) | 1997-05-29 | — | — | WO | disclosed |
| US-5633227-A | POLYPEPTIDE | MILES, INC. (US) | 1997-05-27 | — | — | US | disclosed |
| WO-1996040893-A1 | NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI FOR DIAGNOSTICS AND THERAPEUTICS | ASTRA AKTIEBOLAG (SE) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996033209-A1 | PEPTIDYL DERIVATIVES AS INHIBITORS OF PRO-APOPTOTIC CYSTEINE PROTEINASES | MERCK FROSST CANADA INC. (CA) | 1996-10-24 | — | — | WO | disclosed |
| WO-1996008275-A1 | SECRETORY LEUKOCYTE PROTEASE INHIBITOR AS AN INHIBITOR OF TRYPTASE | BAYER CORPORATION (US) | 1996-03-21 | — | — | WO | disclosed |
| US-5273886-A | Quantitatively methylating isoaspartyl residues in polypeptide fragments in a mixture of labeled S-adenosyl L-methionine in the presence of an L-isoaspartyl methyltransferase | THE REAGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-12-28 | — | — | US | disclosed |